Latest other current liabilities for LSBPW: $380M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest other current liabilities for LSBPW is $380M as of March 2025. That compares with $410M in the prior-year period — down 7.5% year over year. Investors often review this figure alongside LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, LSBPW's other current liabilities moved from $410M to $380M — a 7.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s operating scale or balance-sheet position.
A other current liabilities figure of $380M for LSBPW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting LSBPW's other current liabilities ($380M), review year-over-year change from $410M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.